Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Go back a year and look at the chart for CPXX. The same will happen here.
He has something positive to say in the patent. For some reason he is holding that back. Why??????
Too busy to review with attorney (possibly, remember this is a one man show) or holding for maximum effect (my guess not) or under NDA (no reason to hold up PR for that) or something else. There is really no excuse to hold up unless they are questioning something which doesn't seem to be the case.
While all this bickering is going on, the shorts are covering big time.
I had a significant number of my loan shares returned to me today.
My guess is we will hear news before flag day.
We had a nice run for three days. I think we settle in the .75 - .95 range for a while. Ultimately we will most likely get bought out between $4 and $6 but that's months away. Enjoy the run. It will continue at some point.
We will get our first genuine multi dollar pop when we see a PR that the first patient in the Rett trial was treated.
It's a non event. There is only a couple folks who thought we would experience a significant drop. We may but it won't be due to LPC.
Perhaps this is a case where we went to BMS and asked them to try.
Doc: give it a try. We will cover our part and pay third party costs. All you have to do is just incorporate the study within your other studies. It should be minimal expense to you. You have everything you need.
BMS: oh what the hell. Just to confirm, you are picking up third party expenses?
DOC: yes, we did major dilution 9 months ago so we are flush with cash. Deal?
BMS: deal!
DOC: (too himself)....maybe this will get share price to drop so I can pick up s few more shares and then later this year...BAM, POP, POW...just like Batman...I PR the AXAL news.
I don't think funding is an issue to cause delay. It's basically a one man show so I suspect Missling is busy juggling other things (Rett, upcoming events,etc).
Premarket awlfully quiet with the LPC deal. No tutes seem to care.
Where is the patent news? It's weeks overdue.
Stop you??? The problem is, it seems like we are the only few who believes and can comprehend what we have. With the depth of expertise on our board, I'm just baffled why more folks in the scientific community don't know about us. This is just another example of the "tip of the iceberg" comment. One day everybody is going to wake up at the same time and have an "ah-ha" moment. This will most likely occur once the 12 week data is released on the Rett trial (unless there are early milestones to be shared).
Hey Tom, with all due respect, I feel your point of view is always biased to the negative side. I don't think Friday's news is negative nor do I believe it is a surprise. I will be shocked if we close down more than $0.10. I actually believe, now that the anticipated issuance of shares are known we will be up this next week. Most (if not all investors knew this was coming, especially in the light of the preferred shares getting voted down). The stage is now set for the flow of great news starting with the patent plus approval. I was wondering why the patent news wasn't released. I bet it was "held" up for cursory review by outside counsel.to allow time for the PR on the 5m to be issued. Just my take.
Personally, I believe the trend is up. I expect we will continue to have swings (up. 15%, down 5%). It would be nice to play the swings but anything can happen at his point. I believe we will get bought out within the next 12 months between $5 and $6 per share.
Let's hope. Good luck to everyone.
And Fadiran will help with the first 3 items:
holding meetings with the sponsor and the review team throughout the development of the drug
providing timely advice to, and interactive communication with, the sponsor regarding the development of the drug to ensure that the development program to gather the nonclinical and clinical data necessary for approval is as efficient as practicable
taking steps to ensure that the design of the clinical trials is as efficient as practicable, when scientifically appropriate, such as by minimizing the number of patients exposed to a potentially less efficacious treatment
From another company. Wouldn't it be nice to hear this here
______is under confidentiality agreements with a number of companies for a commercial partnership for the marketing of aldoxorubicin. The Company believes those active discussions may be further advanced by this latest news.
I like it. I've been pretty excited about our prospects, however with this out of the way (I was wondering would Missling would do with the preferred sale being voted down), I feel there is nothing holding back the iceberg. I believe we will see the iceberg being paraded and admired on board street between south and wall st.
We are off to the races!!!!
The future prospects of this company hinges on the upcoming Rett trial. It clearly states it will run UP TO 12 weeks. That means it can be shorter than 12 weeks. We will have a readout before end of year long before AD phase 2/3 trial. If all goes well, then we are golden. AD will be the larger payout but once Rett passes go the AD risk is almost zero. All bets are on the first trial which is Rett.
Perhaps a call to IR asking for clarification. They of coarse will say read the SEC filings and the reply would be "one gives a date of happening in 2017 and the latest has no date, so is the 2017 date still good?" Surely they can answer that one.
I stand corrected. It's even better that they haven't been directed to sell yet. Sell after string of news. We must be getting real close!!! Patent news first. Then 15/18 month data? PK/PD data? Rett starting? Tip of the iceberg!!!!
AD trial will take long to enroll and for readouts. Current AD trial shows this.
The key is the 12 week Rett trial. If this gets going soon we will have a readout by end of year. All we need is to see one successful trial to prove it truly works. I bet the Rett foundation already has the patients identified and their caregivers are just waiting for the Yes moment.
LP can loan the shares out at make 12.625%. Come to think of it, if 5m shares entered the float then why didn't the loan share % go down? One would think the add'l shares would increase shares available to loan and thus lower the interest rate.
My guess is now that this is out of the way we pop and close above 6.41 on Tuesday.
My guess they may be a small and quick sell off without additional news. The add'l 5m shares should not be a surprise. It was part of the proxy and KNOWN. I wouldn't be surprised to hear about the patent come Tuesday morning.
I've seen share prices after dilution because the money was being spent on trials. It looks to me LP is bought the shares at $5.80 and perhaps that is why we traded in this range for so long. They were the ones most likely selling above $5.85.
IMO, this is a non event and with this out of the way the good news will start flowing.
Remember LP bought the sales at $5.80 and we are on our way up not down.
My only concern at this point is the lack of trials starting. The AD trial is taking way too long IMO. If data is good as pontificated and coupled with the anecdotal reports of the painter, piano player and golfer, I would think the Aussie gov't would be doing something to jump start the next phase. If evidence is so strong then the Aussies should have some form of conditional approval and run P3 concurrently with approval. Seems logical and compassionate to do so.
Well, let's see if we get some GOOD news on Tuesday. We are overdo. Especially on the patent thanks to you!!
Zig, true what you said, but what would be better? A) put out positive PR on patent and let it run to x+ and then issue PR on LP and have share price drop to x? or B) issue LP PR AH and then patent PR premarket next week and share price runs to x?
Assuming we get some good news on Tuesday, I would prefer B. They both get to x however B gets us there with less volatility. If Missling is as methodical/thoughtful as most folks think then it should slam dunk conclusion we get positive PR in Tuesday.
I don't think the 5m shares is a big deal because they are most likely being issued instead of the preferred since they were shot down. I believe the smart money (tutes) understand that if the preferred got shot down the company would most likely issue add'l common. What is the other choice? Take on debt? Although, I was surprised by the timing (after hours on a long weekend) I did expect it.
I now wonder if the 15 month data was pulled because Missling saw that it was going to be tough to get the preferred approved and decided to wait until after this event. Maybe he also waited on this to happen to PR the new pAtent. I bet we hear of the new patent on Tuesday premarket.
I think this was due to the preferred being voted down.
Yes and it looks like LP still has about another 1m from last year's deal.
I'm guessing the delay in the patent plus PR is due this offering so I'm thinking we will hear of the patent news next week and as we run LP will be selling shares into the buying spree. My guess is we still reach $7 next week with patent us PR.
And thus today's add'l 5m shares added to our float. Hope it's put to good use.
Today is turning out to be the slowest day (volume wise) in over two years.
So what would be a reasonable target price for a buyout? Appx 153m shares so a 1B MC would be about $6.50/sh. How big is the market for the therapy?
That's what I was thinking earlier in the day... PR plus patent premarket tomorrow and it sink in over the 3 day weekend. Perhaps maybe catch a few shorties off guard as they leave early to extend their weekend. It would be nice however, I don't think the odds are high for it to happen.
I don't think they will ever go away, they will just set up shop at a higher level (45-60 range). :).
5.80 doesn't appear to be that strong looking at the daily chart. It took less that 15 minutes and only 12k shares traded. To me the 5.97 to 6.00 is the tough resistance. I see at least 60k shares in queue in that range. I'm sure there is more but that is all level 2 was showing when the b/a was at 5.95/5.96.
Djia, but doesn't that mean every second that goes by, we are one second closer?
The 12.5 calls are active again today although not the same volume as yesterday. Thus far, 345 for June and 142 for July.
Ahh! LOL! I missed it by a whole month. I need A2-73 now for myself!!
Since next week starts the 2nd half of 2017 anything can happen in one day so perhaps somebody wants to fill their need before the long weekend. It would say something if we break above 5.97 to 6.00. It looks like lots of resistance at this point.
I wonder if today's premarket dump was made by someone attempting to rattle the cages of retail in the hopes of accumulating more on the cheap.
This will be like CPXX last year at this time. CPXX when from $2 to $8 in Feb to Mar on P3 data. Then a double to $16 one month later in April and then another double to $30+ in a buyout in May. So in3 months the stock price when up from $2 to $30+.
It's crazy someone would sell for 0.25 less. If they waited one hour they would have an extra $1,250 in their pocket.
My interpretation is someone is "betting big" that we will be over $10 by June 26th. Let's hope they are correct.
Ignatius, the open interest on the June 12.5 calls is now 400 so it doesn't appear the OI provided is real time. The 400 went off in 2 blocks 200 each. Both at 0.05 and 15 minutes apart. At the time, the b/a was .00/.20 so I'm thinking someone thought to sell covered calls while the share price was up. The share price was between 9.25 and 9.30 when they were executed. Interesting in that the share price didn't go above 9.25 after the options were bought/sold.
I think today's action will be similar to yesterday's. Trend up in the morning 'til about 11 (I think we hit $10) and slow drop to noon (9.50ish) back up over lunch and then in a 0.20 trading range rest of day (all without news) and we close at 9.80.